Article · 2014
Research articlePublished 2012
eNOS and Diabetic Nephropathy
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Diabetic nephropathy (DN) is the leading cause of end stage renal disease (ESRD) and the number of patients with DN has been increasing rapidly. Development of new effective therapeutic strategies of DN is slow at least partly because of a lack of animal models that recapitulate the features of human DN. Human variants of the endothelial nitric oxide synthase gene (eNOS, NOS3 ) that produce reduced amounts of nitric oxide (NO) are positively associated with DN, although proof of causation is lacking. Recently, several investigators have established animal models of advanced DN using mice unable to synthesize eNOS and have demonstrated that eNOS -/- mice with diabetes develop severe nephropathy. It has been also shown that a high fat diet worsens the DN of the diabetic mice lacking eNOS. However, complete absence of eNOS has not been reported in humans, although reduced levels are not infrequent. Accordingly, heterozygous eNOS +/- mice have been made diabetic and they demonstrated that the decrease in eNOS/ NO comparable to that of NOS3 polymorphisms is sufficient to cause exacerbation of DN. Increased expression of tissue factor (TF), initiator of coagulation, plays a significant role in the DN of the eNOS -/- diabetic mice, as well as in diabetic mice having wild type eNOS. Strategies to ameliorate hypercoagulability could be useful for treatment of DN.
Keywords
Subjects
Nephrology & UrologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Conference abstract · 28 May 2018
The natural drug DIAVIT is protective in a type II mouse model of diabetic nephropathy
Conference abstract · 2018
NLRP3 inflammasome expression and urinary HSP72 in relation to biomarkers of inflammation and oxidative stress in diabetic nephropathy patients
Article · 2012
Persistent hyperglycemia generating reactive oxygen species in renal cells, a probable cause of inflammation in type2 diabetic nephropathy subjects
Research article · 2012
Role of Protein Kinase C-MAPK, Oxidative Stress and Inflammation Pathways in Diabetic Nephropathy
More from this journal
The newest in Journal of Nephrology & Therapeutics.
Research article · 15 Apr 2026
Anemia Management in Hemodialysis Patients in a Low-resource Setting: Blood Transfusion and Unmet Blood Needs in Burkina Faso
Brief report · 30 Mar 2026
Renal Fibrosis: Targeting Pathways For New Therapies
Brief report · 30 Mar 2026
SGLT2 Inhibitors: A New Era for Diabetic Kidney Disease
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Nephrology & Therapeutics
- SubjectNephrology & Urology
- BylineArticles whose byline prints “Feng Li”
- BylineArticles whose byline prints “Nobuyuki Takahashi”

